Arshad Mehmood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arshad Mehmood has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
Wahid Shah
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China
7 shared publications- Yi Mo
The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
6 shared publications - Bin Li
Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
5 shared publications Lu Zhang
Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
5 shared publicationsMurad Khan
International Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province, School of Pharmacy & The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, China
4 shared publicationsShuang Song
Department of Neurology The Second Hospital of Hebei Medical University Shijiazhuang Hebei China
4 shared publications
Latest Publications
- 20 August 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (16) , e72237
Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation
Aptamers—short, single‐stranded nucleic acids capable of folding into complex three‐dimensional structures—have evolved from biochemical curiosities into programmable molecular interfaces with expanding diagnostic and therapeutic relevance. Through systematic evolution of ligands by exponential enrichment (SELEX), aptamers exploit the structural plasticity of nucleic acids to achieve high‐affinity and high‐specificity target recognition. Innovations in chemical modification, high‐throughput sequencing, microfluidics, nanotechnology, and artificial intelligence (AI) have redefined aptamer discovery and translational potential. Aptamers transition from antibody alternatives to programmable molecular systems capable of sensing, computation, and controlled actuation in biological environments.
- 20 August 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (16) , e72237
Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation
Aptamers—short, single‐stranded nucleic acids capable of folding into complex three‐dimensional structures—have evolved from biochemical curiosities into programmable molecular interfaces with expanding diagnostic and therapeutic relevance. Through systematic evolution of ligands by exponential enrichment (SELEX), aptamers exploit the structural plasticity of nucleic acids to achieve high‐affinity and high‐specificity target recognition. Innovations in chemical modification, high‐throughput sequencing, microfluidics, nanotechnology, and artificial intelligence (AI) have redefined aptamer discovery and translational potential. Aptamers transition from antibody alternatives to programmable molecular systems capable of sensing, computation, and controlled actuation in biological environments.
- 31 July 2026
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (17) , 7865-7883
Structure-based design of peptide inhibitors targeting the SPSB2–iNOS interaction: a computational approach to modulating nitric oxide signaling
Nitric oxide (NO) is a versatile signaling molecule with critical roles in various physiological processes, including immune surveillance, neurotransmission, and vascular homeostasis (Garthwaite, 2...
- 31 July 2026
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 44 (17) , 7865-7883
Structure-based design of peptide inhibitors targeting the SPSB2–iNOS interaction: a computational approach to modulating nitric oxide signaling
Nitric oxide (NO) is a versatile signaling molecule with critical roles in various physiological processes, including immune surveillance, neurotransmission, and vascular homeostasis (Garthwaite, 2...
- 2 July 2026
- Published by IOP Publishing in Progress in Biomedical Engineering
- Vol. 8 (3) , 032008
Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer’s disease
Heparan sulfate (HS) proteoglycans are abundant, sulfation-patterned glycosaminoglycans on brain cells and the neurovascular unit that interact with amyloid- β (A β ) and tau, aggregate and propagate proteopathic species, and modulate cellular uptake pathways. Aptamers are short, chemically synthesized single-stranded nucleic acids that fold to form high-affinity ligands. Novel aptamers bind specific HS motifs for targeting ligands to deliver RNA therapeutics (siRNA, antisense oligonucleotides, mRNA, RNA aptamer-cargo hybrids) into the brain and diseased cells in Alzheimer’s disease (AD). We cover diagnostic aptamers, systematic evolution of ligands by exponential enrichment (SELEX) approaches adapted for glycans and HS, chemistry, optimization (AI/machine-learning-enabled design), novel therapeutic applications, delivery vehicles and conjugation strategies, catalytic aptamers/ribozymes, and challenges for clinical translation. We propose a workflow— in silico HS motif mapping and machine learning-guided sequence design through microfluidic/ in-vivo SELEX, site-specific chemical modification for nuclease resistance and blood–brain barrier transcytosis, to scalable GMP manufacture. Aptamer-HS technology could enable the precision delivery of RNA therapeutics in AD.
- 2 July 2026
- Published by IOP Publishing in Progress in Biomedical Engineering
- Vol. 8 (3) , 032008
Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer’s disease
Heparan sulfate (HS) proteoglycans are abundant, sulfation-patterned glycosaminoglycans on brain cells and the neurovascular unit that interact with amyloid- β (A β ) and tau, aggregate and propagate proteopathic species, and modulate cellular uptake pathways. Aptamers are short, chemically synthesized single-stranded nucleic acids that fold to form high-affinity ligands. Novel aptamers bind specific HS motifs for targeting ligands to deliver RNA therapeutics (siRNA, antisense oligonucleotides, mRNA, RNA aptamer-cargo hybrids) into the brain and diseased cells in Alzheimer’s disease (AD). We cover diagnostic aptamers, systematic evolution of ligands by exponential enrichment (SELEX) approaches adapted for glycans and HS, chemistry, optimization (AI/machine-learning-enabled design), novel therapeutic applications, delivery vehicles and conjugation strategies, catalytic aptamers/ribozymes, and challenges for clinical translation. We propose a workflow— in silico HS motif mapping and machine learning-guided sequence design through microfluidic/ in-vivo SELEX, site-specific chemical modification for nuclease resistance and blood–brain barrier transcytosis, to scalable GMP manufacture. Aptamer-HS technology could enable the precision delivery of RNA therapeutics in AD.
- 2 June 2026
- Published by Springer Nature in VirusDisease
- Vol. 37 (2) , 106-125
Recombinase polymerase amplification: transforming rapid detection of infectious diseases
- 2 June 2026
- Published by Springer Nature in VirusDisease
- Vol. 37 (2) , 106-125
Recombinase polymerase amplification: transforming rapid detection of infectious diseases
- Open Access
- 15 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (20) , e48690
Clinical analysis of 8 cases of interstitial pregnancy after embryo transfer
This study aimed to improve the diagnosis and treatment of intramural pregnancy (IMP). A retrospective analysis was conducted of 8 cases of IMP admitted between November 2016 and June 2024. Data on patients’ clinical characteristics, diagnosis, treatment, and prognosis were systematically reviewed. All 8 patients experienced IMP following embryo transfer due to tubal factor infertility. Among them, 2 had adenomyosis. All patients had a history of pelvic surgery, including 4 with tubal pregnancy surgery and 2 with uterine cavity surgery. A total of 11 embryos were transferred among the 8 patients, with 8 being high-quality embryos. The fertilization methods included in vitro fertilization and intracytoplasmic sperm injection. The onset of symptoms occurred between 23 and 54 days after embryo transfer. Upon admission, none of the 8 patients exhibited obvious abdominal pain. Preoperative diagnosis included 5 cases of tubal pregnancy and 3 cases of IMP. There were no cases of uterine rupture prior to treatment. All cases were confirmed via combined hysteroscopic and laparoscopic exploration. Among the cases, 6 interstitial pregnancy lesions protruded toward the uterine serosa, 1 slightly into the uterine cavity, and 1 showed no protrusion into either the uterine cavity or the serosa. Cases with gestational lesions slightly protruding into the uterine cavity primarily underwent hysteroscopic resection of the gestational lesion, whereas lesions protruding into the uterine serosa were treated with laparoscopic resection. For cases where the lesion neither protruded into the uterine cavity nor into the serosa, ultrasound-guided local methotrexate (MTX) injection was the primary treatment approach. These cases either received or did not receive systemic MTX treatment as adjuvant therapy. After treatment for gestational lesions, no additional surgeries were performed, and serum human chorionic gonadotropin levels returned to normal within 20 to 90 days. IMP is a rare condition associated with a risk of uterine rupture. Clinical presentations are often atypical, and imaging studies are critical for early diagnosis. Treatment approaches are individualized and may involve surgical resection of gestational lesions, ultrasound-guided embryonic reduction, or local/systemic administration of MTX.
- 15 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (20) , e48690
Open AccessClinical analysis of 8 cases of interstitial pregnancy after embryo transfer
This study aimed to improve the diagnosis and treatment of intramural pregnancy (IMP). A retrospective analysis was conducted of 8 cases of IMP admitted between November 2016 and June 2024. Data on patients’ clinical characteristics, diagnosis, treatment, and prognosis were systematically reviewed. All 8 patients experienced IMP following embryo transfer due to tubal factor infertility. Among them, 2 had adenomyosis. All patients had a history of pelvic surgery, including 4 with tubal pregnancy surgery and 2 with uterine cavity surgery. A total of 11 embryos were transferred among the 8 patients, with 8 being high-quality embryos. The fertilization methods included in vitro fertilization and intracytoplasmic sperm injection. The onset of symptoms occurred between 23 and 54 days after embryo transfer. Upon admission, none of the 8 patients exhibited obvious abdominal pain. Preoperative diagnosis included 5 cases of tubal pregnancy and 3 cases of IMP. There were no cases of uterine rupture prior to treatment. All cases were confirmed via combined hysteroscopic and laparoscopic exploration. Among the cases, 6 interstitial pregnancy lesions protruded toward the uterine serosa, 1 slightly into the uterine cavity, and 1 showed no protrusion into either the uterine cavity or the serosa. Cases with gestational lesions slightly protruding into the uterine cavity primarily underwent hysteroscopic resection of the gestational lesion, whereas lesions protruding into the uterine serosa were treated with laparoscopic resection. For cases where the lesion neither protruded into the uterine cavity nor into the serosa, ultrasound-guided local methotrexate (MTX) injection was the primary treatment approach. These cases either received or did not receive systemic MTX treatment as adjuvant therapy. After treatment for gestational lesions, no additional surgeries were performed, and serum human chorionic gonadotropin levels returned to normal within 20 to 90 days. IMP is a rare condition associated with a risk of uterine rupture. Clinical presentations are often atypical, and imaging studies are critical for early diagnosis. Treatment approaches are individualized and may involve surgical resection of gestational lesions, ultrasound-guided embryonic reduction, or local/systemic administration of MTX.
- Open Access
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48487
Impact of butorphanol combined with propofol general anesthesia on laboratory indicators and reproductive outcomes in elderly patients undergoing oocyte retrieval
This study investigates the impact of butorphanol combined with propofol general anesthesia on laboratory indicators and reproductive outcomes in elderly patients undergoing oocyte retrieval and explores the rationality and safety of its clinical application. A total of 3418 elderly infertile patients underwent transvaginal oocyte retrieval from November 2020 to October 2022. The patients were divided into a control group (non-anesthesia group, n = 250) and a study group (butorphanol combined with propofol general anesthesia group, n = 3168). The basic information (age and body mass index [BMI] of both partners, fertilization method), laboratory indicators (number of oocytes retrieved, fertilization rate, blastocyst formation rate, usable blastocyst rate), and early pregnancy outcome indicators (clinical pregnancy rate, ectopic pregnancy rate, early miscarriage rate) were compared between the 2 groups. There were no statistically significant differences in the age, BMI, and fertilization methods of the couples between the 2 groups ( P > .05). The study group had a higher number of oocytes retrieved than the control group, with a statistically significant difference ( P < .05). However, there were no statistically significant differences in fertilization rate, blastocyst formation rate, and usable blastocyst rate between the 2 groups ( P > .05). There were no statistically significant differences in clinical pregnancy rate, ectopic pregnancy rate, and early miscarriage rate between the 2 groups ( P > .05). Butorphanol combined with propofol general anesthesia can increase the number of oocytes retrieved in elderly patients undergoing oocyte retrieval without affecting other laboratory indicators or pregnancy outcomes, and it can be safely applied in clinical practice.
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48487
Open AccessImpact of butorphanol combined with propofol general anesthesia on laboratory indicators and reproductive outcomes in elderly patients undergoing oocyte retrieval
This study investigates the impact of butorphanol combined with propofol general anesthesia on laboratory indicators and reproductive outcomes in elderly patients undergoing oocyte retrieval and explores the rationality and safety of its clinical application. A total of 3418 elderly infertile patients underwent transvaginal oocyte retrieval from November 2020 to October 2022. The patients were divided into a control group (non-anesthesia group, n = 250) and a study group (butorphanol combined with propofol general anesthesia group, n = 3168). The basic information (age and body mass index [BMI] of both partners, fertilization method), laboratory indicators (number of oocytes retrieved, fertilization rate, blastocyst formation rate, usable blastocyst rate), and early pregnancy outcome indicators (clinical pregnancy rate, ectopic pregnancy rate, early miscarriage rate) were compared between the 2 groups. There were no statistically significant differences in the age, BMI, and fertilization methods of the couples between the 2 groups ( P > .05). The study group had a higher number of oocytes retrieved than the control group, with a statistically significant difference ( P < .05). However, there were no statistically significant differences in fertilization rate, blastocyst formation rate, and usable blastocyst rate between the 2 groups ( P > .05). There were no statistically significant differences in clinical pregnancy rate, ectopic pregnancy rate, and early miscarriage rate between the 2 groups ( P > .05). Butorphanol combined with propofol general anesthesia can increase the number of oocytes retrieved in elderly patients undergoing oocyte retrieval without affecting other laboratory indicators or pregnancy outcomes, and it can be safely applied in clinical practice.
- 19 September 2025
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (5) , 1413-1431
Molecular Pathways of Endothelial Dysfunction Induced by Chronic Social Stress and Therapeutic Interventions
Chronic social stress is increasingly recognized as a significant contributor to endothelial dysfunction, a key precursor to various cardiovascular diseases. This review endeavors to explain the intricate molecular pathways underlying endothelial dysfunction triggered by chronic social stress and to explore its implications for treatment. We summarize the roles of neurotransmitters, neuromodulators, and immune factors in mediating stress-induced vascular changes. We examine recent advances in pharmacology aimed at targeting these pathways, presenting potential avenues for therapeutic intervention. Understanding these molecular mechanisms not only enhances our comprehension of stress-related vascular disorders but also offers the potential for developing targeted therapies to alleviate their adverse effects on cardiovascular health. This review underlines the importance of unraveling molecular pathways and highlights therapeutic opportunities for managing endothelial dysfunction resulting from chronic social stress. Graphical Abstract Chronic social stress has become a significant global issue, impacting various physiological systems and contributing to widespread endothelial dysfunction, a precursor to cardiovascular diseases. This review explores the intricate molecular pathways and discusses neurotransmitters, neuromodulators, and immune factors as mediators of stress-induced vascular changes. Recent pharmacological advancements targeting these pathways offer promising therapeutic interventions. Understanding these mechanisms enhances our comprehension of stress-related vascular disorders and enables the development of targeted therapies to mitigate adverse cardiovascular effects. This review emphasizes the importance of unraveling molecular pathways and highlights therapeutic opportunities for managing endothelial dysfunction resulting from chronic social stress.
- 19 September 2025
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (5) , 1413-1431
Molecular Pathways of Endothelial Dysfunction Induced by Chronic Social Stress and Therapeutic Interventions
Chronic social stress is increasingly recognized as a significant contributor to endothelial dysfunction, a key precursor to various cardiovascular diseases. This review endeavors to explain the intricate molecular pathways underlying endothelial dysfunction triggered by chronic social stress and to explore its implications for treatment. We summarize the roles of neurotransmitters, neuromodulators, and immune factors in mediating stress-induced vascular changes. We examine recent advances in pharmacology aimed at targeting these pathways, presenting potential avenues for therapeutic intervention. Understanding these molecular mechanisms not only enhances our comprehension of stress-related vascular disorders but also offers the potential for developing targeted therapies to alleviate their adverse effects on cardiovascular health. This review underlines the importance of unraveling molecular pathways and highlights therapeutic opportunities for managing endothelial dysfunction resulting from chronic social stress. Graphical Abstract Chronic social stress has become a significant global issue, impacting various physiological systems and contributing to widespread endothelial dysfunction, a precursor to cardiovascular diseases. This review explores the intricate molecular pathways and discusses neurotransmitters, neuromodulators, and immune factors as mediators of stress-induced vascular changes. Recent pharmacological advancements targeting these pathways offer promising therapeutic interventions. Understanding these mechanisms enhances our comprehension of stress-related vascular disorders and enables the development of targeted therapies to mitigate adverse cardiovascular effects. This review emphasizes the importance of unraveling molecular pathways and highlights therapeutic opportunities for managing endothelial dysfunction resulting from chronic social stress.
- Open Access
- 16 January 2025
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 12 (1) , 01-14
Decoding the Puzzle: Research Progress on the Mechanisms of Exercise in Attenuating Diabetic Nephropathy - Insights, Challenges, and Future Directions
A sedentary lifestyle is associated with an increased likelihood of developing diabetes mellitus.
- 16 January 2025
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 12 (1) , 01-14
Open AccessDecoding the Puzzle: Research Progress on the Mechanisms of Exercise in Attenuating Diabetic Nephropathy - Insights, Challenges, and Future Directions
A sedentary lifestyle is associated with an increased likelihood of developing diabetes mellitus.
- Open Access
- 1 January 2025
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 29 (1) , 240-246
LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition
Retrotransposable elements are harmful at several levels, and host surveillance systems fail to consider all these elements in severe effects. The key role of retrotransposon in aging and age-associated diseases remains unclear. We summarise whether LINE-1 retrotransposable elements...
- 1 January 2025
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 29 (1) , 240-246
Open AccessLINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition
Retrotransposable elements are harmful at several levels, and host surveillance systems fail to consider all these elements in severe effects. The key role of retrotransposon in aging and age-associated diseases remains unclear. We summarise whether LINE-1 retrotransposable elements...
- 20 December 2024
- Published by Springer Nature in Current Psychology
- Vol. 44 (1) , 263-274
Examining how body image and narcissism affect the link between perfectionism and body dysmorphic disorder in Chinese students
- 20 December 2024
- Published by Springer Nature in Current Psychology
- Vol. 44 (1) , 263-274
Examining how body image and narcissism affect the link between perfectionism and body dysmorphic disorder in Chinese students